Skip to main content
logo
Alkermes plc (ALKS)
NASDAQ: ALKS · Real-Time Price · USD
37.19
-0.29 (-0.77%)
At close: May 18, 2026, 4:00 PM EDT
36.71
-0.48 (-1.29%)
Pre-market: May 19, 2026, 5:15 AM EDT

Alkermes Revenue

Alkermes had revenue of $392.91M in the quarter ending March 31, 2026, with 28.19% growth. This brings the company's revenue in the last twelve months to $1.56B, up 3.21% year-over-year. In the year 2025, Alkermes had annual revenue of $1.48B, down -5.25%.

Revenue (ttm)
$1.56B
Revenue Growth
+3.21%
P/S Ratio
3.97
Revenue / Employee
$762,098
Employees
2,050
Market Cap
6.20B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20251.48B-81.73M-5.25%
Dec 31, 20241.56B-105.78M-6.36%
Dec 31, 20231.66B551.61M49.61%
Dec 31, 20221.11B-61.95M-5.28%
Dec 31, 20211.17B134.99M13.00%
Dec 31, 20201.04B-132.19M-11.29%
Dec 31, 20191.17B76.68M7.01%
Dec 31, 20181.09B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Elanco Animal Health4.89B
Dr. Reddy's Laboratories3.58B
Neurocrine Biosciences3.10B
Amneal Pharmaceuticals3.05B
Hims & Hers Health2.37B
Lantheus Holdings1.55B
BioCryst Pharmaceuticals885.72M
Supernus Pharmaceuticals776.83M
Revenue Rankings

ALKS News

More News